1. Home
  2. CVKD vs FOXX Comparison

CVKD vs FOXX Comparison

Compare CVKD & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • FOXX
  • Stock Information
  • Founded
  • CVKD 2022
  • FOXX 2017
  • Country
  • CVKD United States
  • FOXX United States
  • Employees
  • CVKD N/A
  • FOXX N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • FOXX
  • Sector
  • CVKD Health Care
  • FOXX
  • Exchange
  • CVKD Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • CVKD 29.5M
  • FOXX 32.2M
  • IPO Year
  • CVKD 2023
  • FOXX N/A
  • Fundamental
  • Price
  • CVKD $12.64
  • FOXX $5.05
  • Analyst Decision
  • CVKD Strong Buy
  • FOXX
  • Analyst Count
  • CVKD 1
  • FOXX 0
  • Target Price
  • CVKD $32.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • CVKD 24.4K
  • FOXX 27.8K
  • Earning Date
  • CVKD 11-06-2025
  • FOXX 10-24-2025
  • Dividend Yield
  • CVKD N/A
  • FOXX N/A
  • EPS Growth
  • CVKD N/A
  • FOXX N/A
  • EPS
  • CVKD N/A
  • FOXX N/A
  • Revenue
  • CVKD N/A
  • FOXX $53,866,257.00
  • Revenue This Year
  • CVKD N/A
  • FOXX N/A
  • Revenue Next Year
  • CVKD N/A
  • FOXX N/A
  • P/E Ratio
  • CVKD N/A
  • FOXX N/A
  • Revenue Growth
  • CVKD N/A
  • FOXX 3899.98
  • 52 Week Low
  • CVKD $8.74
  • FOXX $2.45
  • 52 Week High
  • CVKD $22.90
  • FOXX $12.80
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 48.59
  • FOXX 41.09
  • Support Level
  • CVKD $13.12
  • FOXX $4.75
  • Resistance Level
  • CVKD $13.69
  • FOXX $5.86
  • Average True Range (ATR)
  • CVKD 0.59
  • FOXX 0.62
  • MACD
  • CVKD -0.06
  • FOXX -0.07
  • Stochastic Oscillator
  • CVKD 21.08
  • FOXX 26.60

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: